A London-based sickle cell care pilot program's abrupt end could have dire consequences, warns an MP. The Same Day Emergency Care (SDEC) unit at the Royal London Hospital in Whitechapel, which provided an alternative to A&E admissions for sickle cell patients, was shut down in January. This decision has sparked concern among patients and advocates, who argue that the unit was a lifeline for those suffering from this chronic condition. The unit's closure comes at a critical time, as sickle cell disease is the most common and rapidly growing genetic condition in the UK, particularly affecting people of Black African or Caribbean descent. The blood disorder demands lifelong management of severe, often hospital-requiring sickle cell crises, which are marked by excruciating pain and require powerful painkillers. Labour MP Bell Ribeiro-Addy has issued a stark warning, stating that the end of the emergency care pilot could be fatal. She calls for a national strategy for specialized sickle cell care, emphasizing the need for better support and treatment. The SDEC unit was a beacon of hope for many, offering swift and compassionate care from specialists. Patients like Abi Osei-Mensah, a sickle cell campaigner, have expressed deep disappointment over its closure. Osei-Mensah, who had to endure long waits and advocate for herself in A&E, highlights the unit's effectiveness in providing rapid pain relief. She and others have raised concerns about the communication gap, as many patients were unaware of the unit's existence. The unit's closure has left patients like Delo Biye, who traveled long distances to access it, feeling vulnerable and in pain. The campaign against its closure has gained momentum, with MPs and advocates calling for its reinstatement and a broader rollout of emergency units across London. The issue extends beyond London, as sickle cell care is a national concern, as underscored by the All Party Parliamentary Group for Sickle Cell and Thalassaemia and the Sickle Cell Society's 2021 report, 'No One's Listening'. This report revealed sub-standard care, stigma, and a lack of prioritization for sickle cell patients. The call for a national strategy and improved treatment pathways resonates with MPs like Apsana Begum, whose constituents benefited from the emergency unit. The sudden end to the pilot program has sparked a debate about the future of sickle cell care in the UK, with many advocating for a more comprehensive and supportive approach to address the unique challenges faced by those living with this condition.
